BPG is committed to discovery and dissemination of knowledge
Article Citation
Fu XP. Dual benefits of sodium-glucose cotransporter 2 inhibitors in metabolic diseases: Diabetes control and gout management. World J Clin Cases 2025; 13(14): 100262 [PMID: 40385301 DOI: 10.12998/wjcc.v13.i14.100262]
Please LOGIN to submit a new comment.
Write to the Help Desk